RPRX

Royalty Pharma Plc Earnings

$38.85

Earnings Summary

Revenue	$609.29Mn
Net Profits	$288.22Mn
Net Profit Margins	47.3%

Highlights

Revenue:

Royalty Pharma Plc’s revenue jumped 7.9% since last year same period to $609.29Mn in the Q3 2025. On a quarterly growth basis, Royalty Pharma Plc has generated 5.29% jump in its revenue since last 3-months.

Net Profits:

Royalty Pharma Plc’s net profit fell -47.02% since last year same period to $288.22Mn in the Q3 2025. On a quarterly growth basis, Royalty Pharma Plc has generated 855.12% jump in its net profits since last 3-months.

Net Profit Margins:

Royalty Pharma Plc’s net profit margin fell -50.9% since last year same period to 47.3% in the Q3 2025. On a quarterly growth basis, Royalty Pharma Plc has generated 807.11% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Royalty Pharma Plc post its latest quarter earnings

EPS Estimate Current Quarter	1.31
EPS Estimate Current Year	1.31

Highlights

EPS Estimate Current Quarter:

Royalty Pharma Plc’s earning per share (EPS) estimates for the current quarter stand at 1.31 - a 25.96% jump from last quarter’s estimates.

EPS Estimate Current Year:

Royalty Pharma Plc’s earning per share (EPS) estimates for the current year stand at 1.31.

Key Ratios

Key ratios of the Royalty Pharma Plc post its Q4 2025 earnings

Earning Per Share (EPS)	0
Dividend Per Share (DPS)	0.22

Highlights

Earning Per Share (EPS):

Royalty Pharma Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2025. This indicates that the Royalty Pharma Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Dividend Per Share (DPS):

Royalty Pharma Plc declared 0.22 dividend per share during the earnings announcement for Q4 2025.